18796
Prospective evaluation of efficacy and tolerability in skin phototypes
IV to VI of a topical formulation for hyperpigmentation
combining tranexamic acid with niacinamide, kojic acid, and
hydroxyethylpiperazine ethane
Hema Sundaram, MA, MD, FAAD, Dermatology, Cosmetic, and Laser Surgery
Background: Hyperpigmentation, a source of distress and stigma, has triggers
including skin inflammation, ultravio
28523
Evaluation of a facial serum containing 3% TXA on resistant
hyperpigmentation in darker skin types
Hina Choudhary, SkinCeuticals; Stephen Lynch, PhD, L’Oreal USA;
Uchenna Okereke, The Dermatology Specialists; Valerie Callender,
Callender Dermatology and Cosmetic Center
Introduction: Dyschromia such as postinflammatory hyperpigmentation (PIH) and
melasma are among the 3 most common skin complaints i
Studies from the American academy of dermatologists
Copyright © 2024 JUVELAB - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.